Previous Close | 0.8256 |
Open | 0.8400 |
Bid | 0.7377 x 900 |
Ask | 0.7400 x 1200 |
Day's Range | 0.7040 - 0.8699 |
52 Week Range | 0.3200 - 1.5700 |
Volume | |
Avg. Volume | 1,846,086 |
Market Cap | 150.169M |
Beta (5Y Monthly) | 2.26 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2930 |
Earnings Date | May 10, 2023 - May 15, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 18, 2012 |
1y Target Est | 2.65 |
Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 33.33% and 5.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
BOSTON, March 22, 2023--Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
BOSTON, March 17, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the fourth quarter and full year 2022 financial results and provide a corporate update on Wednesday, March 22, 2023, at 8:30 a.m. Eastern/5:30 a.m. Pacific.